Quick Answer
Hinge Health, Inc. reported Total Revenue of $587.86 million for fiscal year 2025.
Hinge Health, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $587.86M +50.6% |
$390.40M +33.4% |
$292.73M | — |
| Revenue (ASC 606) | $587.86M +50.6% |
$390.40M +33.4% |
$292.73M | — |
| Net Income | -$528.26M -4326.9% |
-$11.93M +89.0% |
-$108.14M | — |
| Diluted EPS | -$7.77 -783.0% |
-$0.88 +89.4% |
-$8.31 | — |
| Total Assets | $744.76M +10.6% |
$673.26M | — | — |
| Cash and Equivalents | $208.00M -30.8% |
$300.79M +28.0% |
$234.95M | — |
| Stockholders Equity | $178.66M +141.1% |
-$434.57M -2.5% |
-$423.99M -33.3% |
-$318.12M |
| R&D Expense | $368.14M +265.1% |
$100.84M -8.4% |
$110.06M | — |
| Operating Income | -$546.37M -1612.2% |
-$31.91M +75.6% |
-$130.51M | — |
| Gross Profit | $468.22M +56.1% |
$299.90M +54.4% |
$194.18M | — |
| Shares Outstanding | 0 -100.0% |
16.38M | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $154.21M | +53.3% | +10.9% |
| Revenue (ASC 606) | September 30, 2025 | $154.21M | +53.3% | +10.9% |
| Net Income | September 30, 2025 | -$1.84M | -640.8% | +99.7% |
| Diluted EPS | September 30, 2025 | -$0.02 | -300.0% | +99.8% |
| Total Assets | September 30, 2025 | $769.80M | — | +11.0% |
| Cash and Equivalents | September 30, 2025 | $261.34M | -2.3% | +10.2% |
| Stockholders Equity | September 30, 2025 | $208.00M | +145.0% | +19.7% |
| R&D Expense | September 30, 2025 | $31.92M | +34.2% | -88.6% |
| Operating Income | September 30, 2025 | -$6.09M | -58.5% | +99.0% |
| Gross Profit | September 30, 2025 | $126.20M | +59.2% | +29.1% |
| Shares Outstanding | September 30, 2025 | 0 | — | — |
- Hinge Health, Inc. reported Total Revenue of $587.86 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +50.6% in Total Revenue compared to the prior fiscal year.
- Hinge Health, Inc. reported Revenue (ASC 606) of $587.86 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +50.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Hinge Health, Inc. reported Net Income of -$528.26 million for fiscal year 2025.
- Hinge Health, Inc. showed a decrease of -4326.9% in Net Income compared to the prior fiscal year.
- Hinge Health, Inc. reported Diluted EPS of $7.77 per share (loss) for fiscal year 2025.
- Hinge Health, Inc. showed a decrease of -783.0% in Diluted EPS compared to the prior fiscal year.
- Hinge Health, Inc. reported Total Assets of $744.76 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +10.6% in Total Assets compared to the prior fiscal year.
- Hinge Health, Inc. reported Cash and Equivalents of $208.00 million for fiscal year 2025.
- Hinge Health, Inc. showed a decrease of -30.8% in Cash and Equivalents compared to the prior fiscal year.
- Hinge Health, Inc. reported Stockholders Equity of $178.66 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +141.1% in Stockholders Equity compared to the prior fiscal year.
- Hinge Health, Inc. reported R&D Expense of $368.14 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +265.1% in R&D Expense compared to the prior fiscal year.
- Hinge Health, Inc. reported Operating Income of -$546.37 million for fiscal year 2025.
- Hinge Health, Inc. showed a decrease of -1612.2% in Operating Income compared to the prior fiscal year.
- Hinge Health, Inc. reported Gross Profit of $468.22 million for fiscal year 2025.
- Hinge Health, Inc. showed an increase of +56.1% in Gross Profit compared to the prior fiscal year.
- Hinge Health, Inc. reported Shares Outstanding of 0 shares for fiscal year 2025.
- Hinge Health, Inc. showed a decrease of -100.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: